Ronald N Jones Selected Research

Soft Tissue Infections

9/2016	In vitro spectrum of pexiganan activity; bactericidal action and resistance selection tested against pathogens with elevated MIC values to topical agents.
2/2015	Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
8/2014	Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel.
4/2014	Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
9/2013	Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010.
5/2013	Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
4/2013	Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
12/2009	Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
5/2007	Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
8/2006	Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald N Jones Research Topics

Disease

150	Infections 01/2019 - 02/2002
32	Respiratory Tract Infections (Respiratory Tract Infection) 05/2017 - 05/2002
29	Pneumonia (Pneumonitis) 11/2017 - 03/2002
17	Sepsis (Septicemia) 10/2016 - 03/2002
16	Bacterial Pneumonia 01/2018 - 06/2010
16	Soft Tissue Infections 09/2016 - 08/2002
11	Urinary Tract Infections (Urinary Tract Infection) 07/2020 - 07/2002
7	Neoplasms (Cancer) 03/2017 - 01/2003
7	Healthcare-Associated Pneumonia 07/2014 - 07/2005
5	Intraabdominal Infections 08/2016 - 07/2005
4	Cross Infection (Nosocomial Infection) 11/2016 - 02/2003
4	Ventilator-Associated Pneumonia 07/2015 - 07/2014
4	Bacterial Infections (Bacterial Infection) 09/2013 - 03/2002
4	Endocarditis 08/2013 - 04/2005
4	Pneumococcal Infections 06/2010 - 11/2002
4	Maxillary Sinusitis 05/2008 - 11/2003
4	Chronic Bronchitis 02/2007 - 09/2002
4	Community-Acquired Infections 07/2005 - 05/2003
3	Communicable Diseases (Infectious Diseases) 07/2020 - 01/2018
3	Bacteremia 04/2016 - 11/2002
3	Meningitis 03/2014 - 01/2003
3	Catheter-Related Infections 05/2008 - 03/2008
3	Sinusitis 05/2007 - 09/2002
3	Otitis Media 02/2007 - 11/2003
2	Cystic Fibrosis (Mucoviscidosis) 11/2017 - 07/2016
2	Gram-Negative Bacterial Infections 01/2017 - 04/2013
2	Gonorrhea 01/2016 - 09/2008
2	Diarrhea 03/2011 - 03/2009
2	Gastroenteritis 03/2009 - 05/2006

Drug/Important Bio-Agent (IBA)

31	Ceftaroline FDA Link 11/2017 - 06/2010
23	FluoroquinolonesIBA 04/2012 - 02/2002
18	Anti-Infective Agents (Microbicides)IBA 07/2020 - 09/2002
17	Cephalosporins (Cephalosporin Antibiotics)IBA 07/2020 - 11/2002
15	Linezolid (Zyvox)FDA Link 04/2014 - 07/2005
14	Tigecycline (Tygacil)FDA Link 06/2013 - 02/2002
12	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 08/2003
12	beta-Lactamases (beta-Lactamase)IBA 04/2014 - 11/2002
12	Vancomycin FDA LinkGeneric 07/2013 - 07/2002
11	ceftazidime drug combination avibactamIBA 03/2017 - 06/2014
11	Pharmaceutical PreparationsIBA 10/2014 - 03/2002
11	Penicillins (Penicillin)FDA Link 03/2014 - 07/2003
10	Carbapenems (Carbapenem Antibiotics)IBA 12/2015 - 11/2002
9	Daptomycin FDA Link 07/2013 - 04/2004
8	oritavancinIBA 01/2017 - 04/2012
8	Gatifloxacin (Zymar)FDA Link 02/2012 - 09/2002
7	Cefepime (Maxipime)FDA LinkGeneric 10/2017 - 03/2002
7	telavancin FDA Link 06/2017 - 08/2010
7	dalbavancinIBA 06/2016 - 02/2006
7	Oxazolidinones (2 Oxazolidone)IBA 02/2015 - 05/2004
7	beta-LactamsIBA 12/2009 - 09/2002
6	Oxacillin (Prostaphlin)FDA LinkGeneric 07/2013 - 12/2004
6	garenoxacinIBA 05/2007 - 05/2002
6	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2007 - 08/2003
5	EchinocandinsIBA 10/2016 - 03/2008
5	CoagulaseIBA 05/2016 - 06/2006
5	solithromycinIBA 01/2016 - 04/2010
5	7- (3- (2- amino- 1- fluoroethylidene)- 1- piperidinyl)- 1- cyclopropyl- 6- fluoro- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 09/2012 - 07/2011
5	peptide deformylaseIBA 11/2011 - 01/2004
5	Cefdinir (Omnicef)FDA LinkGeneric 02/2007 - 11/2003
4	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 05/2021 - 05/2002
4	Tazobactam FDA LinkGeneric 10/2017 - 06/2013
4	MacrolidesIBA 01/2017 - 09/2002
4	Meropenem (Merrem)FDA LinkGeneric 08/2016 - 08/2004
4	ceftobiproleIBA 01/2016 - 05/2008
4	Peptides (Polypeptides)IBA 03/2015 - 03/2008
4	tazobactam drug combination ceftolozaneIBA 10/2014 - 09/2013
4	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 03/2014 - 02/2005
4	AminoglycosidesIBA 04/2012 - 03/2002
4	QuinolonesIBA 07/2010 - 08/2002
4	Levofloxacin (Levaquin)FDA Link 05/2008 - 01/2003
4	Erythromycin (Erycette)FDA LinkGeneric 03/2007 - 07/2003
4	CL 331002 (glycylcycline)IBA 03/2007 - 07/2005
4	TetracyclinesIBA 02/2007 - 07/2005
4	NVP PDF 713IBA 05/2006 - 01/2004
3	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2020 - 09/2003
3	Fusidic Acid (Fucithalmic)IBA 09/2016 - 03/2010
3	Antifungal AgentsIBA 10/2014 - 01/2003
3	avibactamIBA 04/2014 - 01/2012
3	lefamulinIBA 09/2013 - 03/2012
3	Polymyxins (Polymyxin)IBA 09/2013 - 02/2008
3	Methicillin (Metin)FDA Link 07/2013 - 12/2009
3	PleuromutilinsIBA 05/2012 - 02/2002
3	AzolesIBA 07/2011 - 03/2008
3	OmigananIBA 05/2008 - 03/2008
3	LipopeptidesIBA 04/2007 - 11/2004
3	Doxycycline (Periostat)FDA LinkGeneric 12/2004 - 02/2002
2	Cefazolin (Ancef)FDA LinkGeneric 07/2020 - 12/2013
2	cefepime-zidebactamIBA 01/2017 - 01/2017
2	Neomycin FDA LinkGeneric 09/2016 - 01/2006
2	Mupirocin (Bactroban)FDA LinkGeneric 09/2016 - 03/2007
2	LactamsIBA 03/2016 - 12/2015
2	EnzymesIBA 01/2015 - 09/2012
2	ceftolozaneIBA 12/2013 - 06/2013
2	TeicoplaninIBA 06/2012 - 09/2011
2	cefditorenIBA 06/2009 - 06/2008
2	Doripenem FDA Link 04/2009 - 07/2006

Therapy/Procedure

23	Therapeutics 03/2015 - 02/2002
5	Mechanical Ventilators (Ventilator) 01/2018 - 08/2010
5	Catheters 06/2012 - 02/2006
3	Drug Therapy (Chemotherapy) 04/2014 - 01/2003